Tumor suppressing function of SLC16A7 in bladder cancer and its pan-cancer analysis
SLC16A7 exhibits tumor-suppressive properties, with downregulation in most cancers, and is associated with favorable prognosis and enhanced immune responses. SLC16A7 functions as a tumor suppressor in BCa and is associated with improved survival outcomes. These findings suggest that SLC16A7 is a potential biomarker for cancer diagnosis and prognosis.
Authors
- Jiancheng Lv (ORCID: https://orcid.org/0000-0001-6551-3884)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-5592-111X)
- Jiatong Zhou
- Mingjie Xu
Institutions
- Zhejiang University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1186/s12885-025-14345-z
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China